Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.370
-0.060 (-4.20%)
At close: Mar 20, 2026, 4:00 PM EDT
1.380
+0.010 (0.73%)
After-hours: Mar 20, 2026, 7:57 PM EDT
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of $364.62 million as of March 20, 2026. Its market cap has decreased by -33.81% in one year.
Market Cap
364.62M
Enterprise Value
322.38M
1-Year Change
-33.81%
Ranking
Category
Stock Price
$1.37
Market Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from $969.66M to $364.62M, a decrease of -62.40%. That is a compound annual growth rate of -11.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 364.62M | -31.16% |
| Dec 31, 2025 | 529.63M | -15.31% |
| Dec 31, 2024 | 625.39M | -44.17% |
| Dec 29, 2023 | 1.12B | 240.67% |
| Dec 30, 2022 | 328.81M | -13.12% |
| Dec 31, 2021 | 378.45M | -19.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Benitec Biopharma | 395.07M |
| Monopar Therapeutics | 392.07M |
| PureTech Health | 390.41M |
| Anavex Life Sciences | 389.22M |
| Lineage Cell Therapeutics | 386.09M |
| Larimar Therapeutics | 382.59M |
| YD Bio | 381.13M |
| Niagen Bioscience | 379.58M |